Projects per year
Personal profile
Education
- 2006-2013 Ph.D., Graduate Institute of Life Sciences, National Defense Medical Center, Taiwan
- 2004-2006 M.S., School of Medicine, College of Medicine, Taipei Medical University
- 1999-2004 B.S., Department of Medical Laboratory Science and Biotechnology, Taipei Medical University
Experience
- 2022.08- Director, TMU GTP Laboratory, Taipei Medical University, Taipei, Taiwan
- 2022.01- Assistant Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
- 2019.03-2020.06 Assistant Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
- 2016.10-2019.03 Assistant Researcher, Research Center of Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2012.10-2016.10 Research Assistant, Department of Biochemistry and Molecular Cell Biology, School of Medicine, Taipei Medical University
- 2013.09-2016.08 Postdoctoral Research Fellow, Academia Sinica
Research Interests
- 醫學之生化及分子生物
- 幹細胞/再生生物醫學
Fingerprint
Dive into the research topics where Yu-Chih Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 10 Finished
-
探討特發性肺纖維化中SENP1 於 PP4C 的小泛素化調控與肺纖維化
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討特發性肺纖維化中SENP1 於 PP4C 的小泛素化調控與肺纖維化
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討SENP1調控COPD之第二型肺泡細胞之細胞老化機轉
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討B型肝炎相關肝癌中HBx蛋白與其相關之表觀遺傳調控因子促進SENP1表現與癌幹細胞特性：HBx/SENP1之角色與臨床意義(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討SENP1調控COPD之第二型肺泡細胞之細胞老化機轉
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
PEP-sNASP Peptide Alleviates LPS-Induced Acute Lung Injury Through the TLR4/TRAF6 Axis
Wu, Y-C., Hsu, S-P., Hu, M-C., Lan, Y-T., Yeh, E. T. H. & Yang, F-M., Mar 21 2022, In: Frontiers in Medicine. 9, p. 832713 832713.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Small blood stem cells for enhancing early osseointegration formation on dental implants: a human phase I safety study
Feng, S. W., Su, Y. H., Lin, Y. K., Wu, Y. C., Huang, Y. H., Yang, F. H., Chiang, H. J., Yen, Y. & Wang, P. D. Y., Dec 2021, In: Stem Cell Research and Therapy. 12, 1, 380.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))
Lai, S. C., Su, Y. T., Chi, C. C., Kuo, Y. C., Lee, K. F., Wu, Y. C., Lan, P. C., Yang, M. H., Chang, T. S. & Huang, Y. H., Jan 13 2020, In: Journal of experimental & clinical cancer research : CR. 39, 1, 1 p., 10.Research output: Contribution to journal › Comment/debate › peer-review
Open Access2 Citations (Scopus) -
Limited effects of antibiotic prophylaxis in patients with Child–Pugh class A/B cirrhosis and upper gastrointestinal bleeding
Chang, T. S., Tsai, Y. H., Lin, Y. H., Chen, C. H., Lu, C. K., Huang, W. S., Yang, Y. H., Chen, W. M., Hsieh, Y. Y., Wu, Y. C., Tung, S. Y. & Huang, Y. H., Jan 1 2020, In: PLoS ONE. 15, 2, e0229101.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Lai, S. C., Su, Y. T., Chi, C. C., Kuo, Y. C., Lee, K. F., Wu, Y. C., Lan, P. C., Yang, M. H., Chang, T. S. & Huang, Y. H., Nov 26 2019, In: Journal of Experimental and Clinical Cancer Research. 38, 1, 474.Research output: Contribution to journal › Article › peer-review
Open Access57 Citations (Scopus)
Datasets
-
MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Lai, S. (Contributor), Wu, Y. (Contributor), Chi, C. (Contributor), Lan, P. (Contributor), Lee, K. (Contributor), Yang, M. (Contributor), Su, Y. (Creator), Chang, T. (Contributor), Kuo, Y. (Contributor) & Huang, Y. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11273585.v1, https://doi.org/10.6084%2Fm9.figshare.11273585.v1
Dataset